The direction of research into adjuvant systemic therapy for breast cancer has been determined in large part by historical and cultural differences between Europe and the United States
Michael Baum, MD
Advertisement
Articles by Michael Baum, MD
Advertisement
Latest Updated Articles
- Historical and Cultural Determinants in the Evolution of Adjuvant Endocrine Therapy
Published: June 15th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
What Do Physicians and Patients Think About ADCs as Cancer Treatment?
3
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
4
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
5
